About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Salbutamol Tolerance Onset

NCT01338311·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Saskatchewan

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

male or female
18 to 65 years of age
non smoker
beta agonist naive for at least 14 days
baseline FEV1 at least 70% predicted
no respiratory tract infection or allergen exposure (if atopic) within 4 weeks of visit 1

You may not be if

poorly controlled asthma
pregnant or lactating women

The record

StatusCompleted

PhasePhase 4

Taking part15

StartedMar 2011

UpdatedJul 20, 2012

Conditions

Where1

University of Saskatchewan
Saskatoon, Saskatchewan, Canada

Clareo Health | Salbutamol Tolerance Onset